MetLife (MET) PT Lowered to $78 at BMO Capital

April 9, 2026 11:44 AM

BMO Capital analyst Jack Matten lowered the price target on MetLife (NYSE: MET) to $78.00 (from $80.00) while maintaining a Market Perform rating.

No results found